Clene to Present at Upcoming September Investor Conferences
Clene (CLNN) will present at two September 2026 investor conferences and host one-on-one investor meetings.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Clene (CLNN) will present at two September 2026 investor conferences and host one-on-one investor meetings.
The company presents at the 2026 Cantor Global Healthcare Conference/b) on at 9:10 a.m. ET in New York, and at the HC Wainwright 28th Annual Global Investment Conference on September 15, 2026 at 1:30 p.m. ET, also in New York. Webcasts will be available via Clene’s website “Events” section or the provided webcast links.
Details
News Market Reaction – CLNN
On Sep 3, the day this news came out, CLNN closed 3.97% below the previous close. Argus tracked a trough of -4.5% from its starting point during tracking. Our momentum scanner recorded 2 alerts for this stock that day. Relative volume reached 2.0x the daily average during tracking.
Data tracked by StockTitan Argus for the Sep 3 session.
Key Figures
- Cantor presentation date
- September 9, 2026
- 2026 Cantor Global Healthcare Conference
- Cantor presentation time
- 9:10am ET
- 2026 Cantor Global Healthcare Conference
- H.C. Wainwright presentation date
- September 15th, 2026
- H.C. Wainwright 28th Annual Global Investment Conference
- H.C. Wainwright presentation time
- 1:30pm ET
- H.C. Wainwright 28th Annual Global Investment Conference
- Meeting format
- 1x1 investor meetings
- Both investor conferences
Historical Context
-
Emerging Growth Conference presentation and investor meetings announcement
-
Quarterly results, financing developments, and ALS regulatory update
-
Biomarker analyses supporting planned ALS accelerated approval submission
-
Canaccord conference presentation and investor meetings announcement
-
Regulatory progress and first-quarter financial results announcement
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
SALT LAKE CITY, Sept. 03, 2026 (GLOBE NEWSWIRE) -- Clene Inc. (Nasdaq: CLNN) today announced that management will present at the 2026 Cantor Global Healthcare Conference and at the H.C. Wainwright 28th Annual Global Investment Conference and host 1x1 investor meetings at both conferences.
2026 Cantor Global Healthcare Conference
Date: September 9, 2026
Time of Presentation: 9:10am ET
Location: New York, NY
Format: Presentation and 1x1 meetings
1x1 Meetings: Please contact your Cantor representative
Webcast: link to webcast
HC Wainwright 28th Annual Global Investment Conference
Date: September 15th, 2026
Time of Presentation: 1:30pm ET
Location: New York, NY
Format: Presentation and 1x1 meetings
1x1 Meetings: Please contact your H.C. Wainwright representative
Webcast: link to webcast
A webcast of the presentation will be available on the “Events” section of the Clene website or using the webcast links above.
About Clene
Clene Inc., (Nasdaq: CLNN) (along with its subsidiaries, “Clene”) and its wholly owned subsidiary Clene Nanomedicine Inc., is a late clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, including amyotrophic lateral sclerosis, Parkinson’s disease, and multiple sclerosis. CNM-Au8® is an investigational first-in-class therapy that improves central nervous system cells’ survival and function via a mechanism that targets mitochondrial function and the NAD pathway while reducing oxidative stress. CNM-Au8® is a federally registered trademark of Clene Nanomedicine, Inc. The company is based in Salt Lake City, Utah, with R&D and manufacturing operations in Maryland. For more information, please visit www.clene.com or follow us on X (formerly Twitter) and LinkedIn.
Investor Contact: Kevin Gardner, LifeSci Advisors; kgardner@lifesciadvisors.com; 617-283-2856
Media Contact: Caroline Wagner, FTP; CWagner@ftpadvocacy.com; (267) 294-6563
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
When will Clene (CLNN) present at the 2026 Cantor Global Healthcare Conference?
Clene is scheduled to present at the 2026 Cantor Global Healthcare Conference on September 9, 2026 at 9:10 a.m. ET in New York, New York. The format includes a presentation and one-on-one investor meetings.
What are the details of Clene (CLNN)’s presentation at the HC Wainwright 28th Annual Global Investment Conference?
Clene will present at the HC Wainwright 28th Annual Global Investment Conference on September 15, 2026 at 1:30 p.m. ET in New York, New York. The company will give a presentation and hold one-on-one investor meetings.
How can investors schedule 1x1 meetings with Clene (CLNN) at these September 2026 conferences?
For the 2026 Cantor Global Healthcare Conference, investors should contact their Cantor representative to arrange one-on-one meetings. For the HC Wainwright 28th Annual Global Investment Conference, investors should contact their H.C. Wainwright representative to schedule 1x1 meetings with Clene.
How can investors access the webcasts of Clene (CLNN)’s September 2026 conference presentations?
Webcasts of Clene’s presentations at both the Cantor Global Healthcare Conference and the HC Wainwright 28th Annual Global Investment Conference will be available on the “Events” section of Clene’s website or through the specific webcast links provided for each conference.